Algeria criticizes Novo Nordisk over insulin supplies and slow collaboration
The minister of the pharmaceutical industry in Algeria claims that Novo has not lived up to deals concerning insulin supply and production, and warns of economic sanctions.
by mikkel holmgaard winding, translated by catherine brett
Algeria’s Minister of the Pharmaceutical Industry Lofti Benbahmed has criticized Novo Nordisk’s activities in the country, saying they have ”failed at all levels.”
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
New Novo Nordisk treatment targets 25% weight loss
For subscribers
